US FDA Converges With Other Regulators On Insomnia Drug Warnings, But Broader Safety Disagreements Persist

 
• By Michael Cipriano
  
Moon
A set of insomnia drugs will come with more restrictive labeling.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet